|
CAS番号. | 23152-29-6 |
化学名: | N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-] |
别名: | バージニアマイシンS1;スタフィロマイシンS1;ファクターS;N-[(3-ヒドロキシ-2-ピリジニル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-ピペコロイル-L-フェニルGly-];ファクターS【抗生物質】;N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-];抗生物質1754Z3B;スタフィロマイシンS;N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ(L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-2-ピペリジンカルボニル-L-フェニルGly-);バージニアマイシンS |
英語化学名: | Virginiamycin S1 |
英語别名: | Antibiotic 899;Staphylomycin S;Verginiamycin S1;Virginiamycin S1;Antibiotic 1754Z3B;VirginiaMycin coMplex;Antibiotic 899, Staphylomycin S;StaphyloMycin S, PA 114B2, 899, A1745Z3B, Factor S;N-[(3-Hydroxy-2-pyridinyl)carbonyl]cyclo[L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-4-oxo-L-pipecoloyl-L-phenyl Gly-];N-[(3-Hydroxy-2-pyridyl)carbonyl]cyclo(L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-4-oxo-L-2-piperidinecarbonyl-L-phenyl Gly-) |
CBNumber: | CB4887230 |
分子式: | C43H49N7O10 |
分子量: | 823.899 |
MOL File: | 23152-29-6.mol |
|
|
|
|
N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-] 物理性質 |
|
N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-] 化学特性,用途語,生産方法 |
使用
Virginiamycin complex is defined as a mixture of 75% ostreogrycin A (virginamycin M1) and 25% virginiamycin S1, together with the less abundant S analogues. As the two major components have quite different solubilities, these proportions are not readily achieved or used. BioAustralis has isolated and re-combined the individual components to provide the defined components of virginiamycin complex. The composition of the complex is important as Virginiamycin S1 acts a synergist, binding to the conformational change of the peptidyl transferase centre of the 50S ribosome induced by ostreogrycin A. |
|
使用
Virginiamycin S1 is one of a family of depsipeptide antibiotics co-produced with ostreogrycin A and used as a synergistic mixture. Virginiamycin S1, also known as Staphylomycin S and Factor S among other synonyms, was discovered independently and named by several groups, leading to considerable confusion in the literature. Virginiamycin S1 acts a synergist, binding to the conformational change of the peptidyl transferase centre of the 50S ribosome induced by ostreogrycin A. Virginiamycin S1 differs from virginiamycin B in lacking the dimethylamino moiety on the phenyl ring. |
|
|
N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-] 上流と下流の製品情報 |
原材料
|
準備製品
|
N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-] 生産企業 Global( 5)Suppliers |
|
|
|
|
23152-29-6(N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-]) キーワード: |
2-[(2-ピリジニルメチル)アミノ]エタノール
rac-(2R*)-2-(アセチルアミノ)-2-フェニル酢酸
1-ブチル-4-ピペリジノン
3-ヒドロキシピコリンアミド
3-ヒドロキシピコリノイル-シクロ[L-Thr*-D-Abu-L-Pro-4-メチルアミノ-N-メチル-L-Phe-4-オキソ-L-Hpr-L-フェニルGly-]
N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-]
1-アセチル-4-ピペリドン
1-プロピルピペリジン-4-オン
1-エチル-2-ピペリジンメタンアミン
|
23152-29-6
Virginiamycin S1
Antibiotic 1754Z3B
N-[(3-Hydroxy-2-pyridinyl)carbonyl]cyclo[L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-4-oxo-L-pipecoloyl-L-phenyl Gly-]
N-[(3-Hydroxy-2-pyridyl)carbonyl]cyclo(L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-4-oxo-L-2-piperidinecarbonyl-L-phenyl Gly-)
Staphylomycin S
Antibiotic 899, Staphylomycin S
Cebin V, Eskalin V, EskaMicin, Stafac, StephyloMycin, MikaMycin, Ostreogrycin, Patricin, PristinaMycin, StreptograMin, VernaMycin.
VirginiaMycin coMplex
StaphyloMycin S, PA 114B2, 899, A1745Z3B, Factor S
Verginiamycin S1
Antibiotic 899
バージニアマイシンS1
スタフィロマイシンS1
ファクターS
N-[(3-ヒドロキシ-2-ピリジニル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-ピペコロイル-L-フェニルGly-]
ファクターS【抗生物質】
N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-]
抗生物質1754Z3B
スタフィロマイシンS
N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ(L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-2-ピペリジンカルボニル-L-フェニルGly-)
バージニアマイシンS
|
Copyright 2007 © ChemicalBook. All rights reserved |